Gastric Cancer Management and Outcomes

SEP 15, 2026 · JOURNAL ARTICLE

The Effect of Lymph Node Status on Clinical Examination and After Neoadjuvant Therapy and Surgery (cN and ypN) on Long-Term Outcomes in Patients with Locally Advanced Gastric Cancer

Voprosy Onkologii

The source record carries too little text to support an evidence assessment.

SEP 12, 2026 · JOURNAL ARTICLE

Association of immune-related adverse events with early tumor shrinkage, depth of response, and survival outcomes in advanced gastric cancer treated with immune checkpoint inhibitors

BMC Cancer

A retrospective single-centre cohort of 49 patients with a clear association between irAEs and improved OS and PFS, but limited by small sample size, single-institution design, and lack of a randomized comparator, requiring confirmation in prospective or larger studies.

SEP 11, 2026 · JOURNAL ARTICLE

Association of Cachexia-Related Status With Treatment Outcomes in Advanced Gastric Cancer Receiving First-Line Therapy With or Without Nivolumab

Journal of Gastrointestinal Cancer

Retrospective cohort study identifying mGPS 2 as a time-dependent predictor of overall survival in advanced gastric cancer, but with modest sample size, observational design, and no practice-changing effect size or mechanistic clarity.

SEP 11, 2026 · JOURNAL ARTICLE

Gastric metastasis from colorectal cancer: an updated comprehensive review of epidemiology, mechanisms, diagnosis, and management

Frontiers in Oncology

A narrative review synthesizing case reports and empirical estimates of a rare condition with acknowledged lack of large-scale epidemiological data, offering descriptive and mechanistic insight but no original empirical evidence or comparative outcomes.

SEP 11, 2026 · JOURNAL ARTICLE

Esomeprazole inhibits EGF-induced invasion and migration of gastric cancer cells

Peerj

In vitro mechanistic study demonstrating that esomeprazole modulates a signaling pathway implicated in gastric cancer cell invasion; raises a question about therapeutic potential rather than answering one in a clinical or animal model.

SEP 9, 2026 · REVIEW

Survival benefit and toxicity trade-offs of first-line chemoimmunotherapy in advanced gastric and gastroesophageal junction cancer: a meta-analysis of randomized trials

Frontiers in Oncology

A high-quality meta-analysis of 7 RCTs with 6,517 patients showing consistent survival and response benefit for chemoimmunotherapy, but with quantified and clinically relevant toxicity trade-offs that require individualised patient selection.

SEP 9, 2026 · JOURNAL ARTICLE

Gastric Mucosa Cancer Risk: The Operative Link on Gastritis Assessment Staging System

The Korean Journal of Helicobacter and Upper Gastrointestinal Research

A narrative review synthesizing evidence on gastric atrophy staging and risk stratification to inform clinical surveillance strategy and serological monitoring in individual patients.

SEP 9, 2026 · JOURNAL ARTICLE

Response of HER2 positive gallbladder adenocarcinoma to trastuzumab emtansine (T-DM1): a case report and literature review

Frontiers in Oncology

A single case report with a favorable outcome in HER2-positive gallbladder cancer treated with trastuzumab emtansine; raises a hypothesis for future investigation but lacks comparative design, control, or replication.